News By Tag
* More Industries...
News By Location
Thomas Platts-Mills, to Present at GTC’s Allergy Drug Discovery Conf., San Diego, Jan 31-Feb1
Thomas Platts-Mills, will present‘The Significance of IgE Antibodies to Galactose-alpha -1, 3-Galactose (alpha-gal)’ at GTC’s 2nd Allergy & Respiratory Drug Discovery Conference taking place in San Diego, CA on January 31 – February 1, 2013.
In 2008, Dr. Platts-Mills’
Thomas A. E. Platts-Mills, Ph.D., is the Oscar Swineford Jr. Professor of Medicine and head of the Asthma and Allergic Disease Center at the University of Virginia. Dr. Platts-Mills has carried out research in many different aspects of the role of indoor allergens in asthma.
Dr. Platts-Mills is the former president of the American Academy of Allergy Asthma and Immunology (AAAAI) and has been active in educational efforts nationally for twenty years. He has published over 300 papers and has been a member of the Editorial Board of more than 10 journals. In addition, he was a member of the Immunological Sciences Study Section for the NIH and in 2003, was chairman of the special interest study section on Asthma and Allergic disease for NIAID.
Dr. Platts-Mills has also served on the NAEPP for NHLBI. He has trained more than twenty specialists in Allergic Disease and has supervised eight PhD’s. He received his degree in Animal Physiology from Oxford University (1963) and his MD from St Thomas Hospital. In 1981 he was made a member of the Royal College of Physicians in London and became a fellow in 1982. He did his training in Allergy and Immunology with Dr. Ishizaka and Dr. Lictenstein at John Hopkins (1971-1974) and in 1983 received a PhD in Immunology from London University. He became a member of the Royal Society in 2010.
This conference is also part of 2nd Novel Immunotherapeutics Summit, (http://www.gtcbio.com/
11th Cytokines & Inflammation
5th Immunotherapeutic & Immunomonitoring
Immunogenicity & Immunotoxicity
Over 200 leading industrial and academic experts will present at this two-day summit. The Novel Immunotherapeutics Summit will offer an in-depth examination of the challenges involved in the dynamic and ever-changing field of drug discovery and development.
For more information, please visit www.gtcbio.com/